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論文の要旨 
Abstract of thesis 
1. PURPOSE: 
Direct reprogramming of fibroblasts into induced cardiomyocytes (iCMs) holds great promise 
for cardiac regenerative medicine. Several mechanisms of iCM-reprogramming have been studied 
so far; however, cell-cycle regulation during iCM-reprogramming has not. The applicant aimed 
to understand cell-cycle regulation of reprogrammed iCMs and to investigate how cell-cycle 
manipulation affects iCM-reprogramming. 
2. METHODS & RESULTS: 
For iCM-reprogramming, αMHC-GFP mouse embryonic fibroblasts (MEFs) were infected with three 
monocistronic retroviruses of Gata4, Mef2c, and Tbx5 (GMT). The time-lapse recordings at day 
2 post-infection (DPI-2) demonstrated that MEFs were initially reprogrammed into αMHC-GFP+ 
iCMs with faint fluorescence (GFPlow) and then gradually gained more intense fluorescence 
(GFPhigh). EdU proliferation assays showed that GFPhigh iCMs contained much less EdU+ cells 
and expressed many cardiac genes significantly higher than GFPlow cells, demonstrating a 
relatively more advanced reprogramming of GFPhigh iCMs.  The applicant found by time-lapse 
recordings that nearly half of GMT-iCMs divided within 48 hours after the activation of 
αMHC-GFP and showed by EdU proliferation assays that iCMs exited cell cycle along the 
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 process of reprogramming with a decreased percentage of EdU+/αMHC-GFP+ cells. S-phase 
synchronization by Aphidicoline, Hydroxyurea, and L-mimosine for 24 hrs at DPI-1 
significantly enhanced cell-cycle exit of GMT-iCMs. Noticeably, compared to monocistronic 
GMT, polycistronic MGT (Mef2c-P2A-Gata4-T2A-Tbx5) facilitated cell-cycle exit and yielded 
significantly higher portion of GFPhigh iCMs. Importantly, S-phase synchronization increased 
the yield of GFPhigh iCMs reprogrammed by GMT, but failed to further accelerate the 
progression of MGT-reprogramming, suggesting that both S-phase synchronization and MGT 
accelerated reprogramming through enhanced cell cycle exit. 
In summary, iCMs were induced majorly at late-G1 and S phases, did go through cell division 
at the early stage of reprogramming, and ultimately exited cell cycle at G0/G1 phase during 
the process of reprogramming. Importantly, S-phase synchronization at the critical 
reprogramming-initiation time (DPI-1) or polycistronic MGT facilitated the early progression 
of GMT-reprogramming and yielded more GFPhigh iCMs, which are relatively higher quality iCMs 
among the reprogrammed cells, through enhancing cell-cycle exit. 
3. DISCUSSION & FUTURE DIRECTION: 
The facilitated cell-cycle exit by S-phase synchronization at DPI-1 was accompanied with an 
improved progression of GMT-reprogramming and yielded significantly more GFPhigh iCMs, which 
achieved a more advanced reprogramming than GFPlow cells. This might be due to that cell-
cycle exit prevents a dilution of GMT expression in individual iCMs and subsequently induce 
high cardiac gene expression and better reprogramming. It is also true in iCM-reprogramming 
of polycistronic MGT, which accelerated cell-cycle exit and yielded more GFPhigh iCMs. 
Because of this accelerated progression of MGT-reprogramming,  S-phase synchronization 
failed to further increase the GFPhigh portion in MGT-iCMs. It has been shown that active 
cell-cycle status and maturity have negative correlation in iCMs. On the other hand, it has 
been observed that iCM-reprogramming was significantly suppressed in an immortalized cardiac 
fibroblast line that will never exit cell cycle, indicating the importance of cell-cycle 
exit in iCM-reprogramming.  All these mark the importance of maintenance of cell cycle 
activation at the early stage of reprogramming and the necessity of cell-cycle exit on 
maturation of iCMs as possibly similar to process of maturation in native mammalian 
cardiomyocytes. Recently, it has been demonstrated that cell-cycle inactive fibroblasts 
failed to be reprogrammed, suggesting that cell-cycle activation could be necessary for 
initiation and early progression of iCM-reprogramming. Similarly, the applicant showed 
nearly half of iCMs at early stage of reprogramming divided. On the other hand, this study 
revealed the impact of induced cell-cycle exit on iCM maturation. In vivo reprogramming 
constitutes the most important part of the cardiac reprogramming technology; however, it is 
still not translatable to real-life cases as cardiac fibroblasts in the chronic type of 
ischemic heart disease are quiescent (cell-cycle inactive). Collectively, the findings by 
others and the applicant indicate that the quiescent cardiac fibroblasts in fibrotic scar in 
 vivo might need to be cell-cycle activated prior to initiation of reprogramming, which in 
turn could increase the number of in vivo iCMs and improve heart function better. Therefore, 
novel methods should be generated for cell-cycle activation of quiescent cardiac fibroblasts 
for in vivo reprogramming. Moreover, rather than acute myocardial-infarction in animal 
models, chronic models of heart diseases should be employed in cardiac reprogramming studies 
as to mimic regeneration of damaged heart in real disease situations in human patients. 
 
 
 
 
審査の要旨 
 Abstract of assessment result 
 
【批評 Review】 
The applicant hypothesis is that direct reprogramming efficiency into iCMs is influenced by 
cell cycle.  He tested carefully his hypothesis by a series of experiments and confirmed that 
precedent cell cycle synchronization and cell cycle exit are important for direct reprograming 
into cardiomycytes.  His findings will help understanding molecular mechanism of direct 
reprogramming and efficiency for clinical use.   
 
【最終試験の結果 Result】 
The final examination committee conducted a meeting as a final examination on 25 December, 
2017. The applicant provided an overview of dissertation, addressed questions and comments 
raised during Q&A session. All of the committee members reached a final decision that the 
applicant has passed the final examination.  
 
【結論 Conclusion】 
Therefore, the final examination committee approved that the applicant is qualified to be 
awarded Doctor of Philosophy in Human Biology. 
 
